Nathan D. Wong, MPH, PhD discusses the evolution of Lp(a) in risk assessment, given its role as a genetic risk factor for cardiovascular complications.
Nathan D. Wong, MD, PhD
Advertisement
Nathan D. Wong, MD, PhD, a professor of medicine and director of the Heart Disease Prevention Program at the University of California, Irvine
Articles by Nathan D. Wong, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Weight Loss Improves Cardiometabolic Biomarkers in Digital Metabolic Reset Program
2
GLP-1 RAs Show Renal, Survival Benefits in Kidney Transplant Recipients With Type 2 Diabetes
3
Diabetes Increases Mortality Risk Across All Major Organ Transplants
4
How to Counsel Patients About Skincare Safety, Sunscreen Safety, and Product Ingredients
5